Elevance Health is reaffirming that shareholders’ adjusted net income guidance for full year 2025 will be $34.15 to $34.85 per diluted share.
The company said in an April 17 regulatory filing that its first quarter results will reflect medical cost trends that are in line with its original expectations, including within its Medicare Advantage business. Elevance noted that MA costs have remained high, but it still expects to enroll 2.2 to 2.25 million MA members by the end of 2025.
Elevance will publish its first quarter financial results on April 22.
The filing follows an “unusual and unacceptable” Q1 performance from UnitedHealth Group, which reduced its year-end earnings outlook April 17 amid rising use of physician and outpatient services among its Medicare Advantage membership and “unanticipated changes in the profile of Optum Health members.”
Following the news, UnitedHealth’s stock decreased 20%, its largest single day drop since the late 1990s.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
